Abstract
Purpose of Review
This review summarizes the current knowledge and evidence behind the diagnosis and management of adult status epilepticus (SE) in the Emergency Department (ED). It incorporates the most recent evidence-based diagnostic and management strategies, while reflecting them back onto the foundational aspects of SE care.
Recent Findings
Recent studies have re-emphasized the importance of early and appropriately dosed benzodiazepines as first-line therapy for SE. Second-line therapy has evolved from phenytoin to alternative anti-epileptics (AEDs) like levetiracetam. Additionally, cerebral perfusion-computed tomography (PCT) and electroencephalogram (EEG) are critical in the diagnosis of non-convulsive SE (NCSE) in the ED.
Summary
Early and aggressive medical management is crucial to curb the morbidity and mortality of adult SE in the ED starting with benzodiazepines and progressing to AEDs. Patients who remain altered after treatment may still have NCSE. Due to the clinical subtleties associated with NCSE, it is essential to utilize tools such as alternative EEG monitoring and PCT.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sculier C, Gainza-Lein M, Sanchez Fernandez I, Loddenkemper T. Long-term outcomes of status epilepticus: a critical assessment. Epilepsia. 2018;59(Suppl 2):155–69. https://doi.org/10.1111/epi.14515.
Ko N, Engelhard K. Neurocritical Care. In: Gropper M, editor. Miller's Anesthesia. Ninth edition ed. Elsevier. 2020;2671–93.
Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol. 1973;28(1):1–9. https://doi.org/10.1001/archneur.1973.00490190019001.
Ruegg S. Time is brain: treating status epilepticus Epigraph. 2018;20(2).
Zaccara G, Giannasi G, Oggioni R, Rosati E, Tramacere L, Palumbo P, et al. Challenges in the treatment of convulsive status epilepticus. Seizure. 2017;47:17–24. https://doi.org/10.1016/j.seizure.2017.02.015.
Neligan A, Noyce AJ, Gosavi TD, Shorvon SD, Kohler S, Walker MC. Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and meta-analysis. JAMA Neurol. 2019;76(8):897–905. https://doi.org/10.1001/jamaneurol.2019.1268.
Sanchez Fernandez I, Goodkin HP, Scott RC. Pathophysiology of convulsive status epilepticus. Seizure. 2019;68:16–21. https://doi.org/10.1016/j.seizure.2018.08.002.
Opdam H. Status Epilepticus. In: Bersten AD, Handy JM, editors. Oh's intensive care manual. Eighth edition. ed. S.l.: Elsevier. 2019;643–50.
Huff JS, Murr N. Psychogenic nonepileptic seizures. StatPearls. Treasure Island (FL). 2022.
Walker MC. Pathophysiology of status epilepticus. Neurosci Lett. 2018;667:84–91. https://doi.org/10.1016/j.neulet.2016.12.044.
•• Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103–13. https://doi.org/10.1056/NEJMoa1905795. The ESETT Trial was a randomized, blinded, adaptive trial evaluating anti-epileptic drugs in pediatric and adult patients finding that levetiracetam, valproate, and fosphenytoin had similar efficacy in seizure cessation in SE.
Navarro V, Fischer C, Convers P. Differential diagnosis of status epilepticus. Rev Neurol (Paris). 2009;165(4):321–7. https://doi.org/10.1016/j.neurol.2008.11.005.
Meziane-Tani A, Foreman B, Mizrahi MA. Status epilepticus: work-up and management in adults. Semin Neurol. 2020;40(6):652–60. https://doi.org/10.1055/s-0040-1719112.
Gloss DS. Status Epilepticus. In: Layon AJ, Gabrielli A, Yu M, Wood KE, editors. Civetta, Taylor & Kirby's critical care. Fifth edition ed. Philadelphia: Wolters Kluwer. 2018;1589–602.
Teran F, Harper-Kirksey K, Jagoda A. Clinical decision making in seizures and status epilepticus. Emerg Med Pract. 2015;17(1):1–24; quiz -5.
Mayer SA, Marshall RS. Acue seizures and status epilepticus. In: On call neurology. Elsevier. 2021;46–67.
Sutter R, Dittrich T, Semmlack S, Ruegg S, Marsch S, Kaplan PW. Acute systemic complications of convulsive status epilepticus-a systematic review. Crit Care Med. 2018;46(1):138–45. https://doi.org/10.1097/CCM.0000000000002843.
Sutton F, Barca D, Komoltsev I, Craiu D, Guekht A, von Oertzen T, et al. Testing blood and CSF in people with epilepsy: a practical guide. Epileptic Disord. 2020;22(4):381–98. https://doi.org/10.1684/epd.2020.1191.
Guerriero RM, Gaillard WD. Imaging modalities to diagnose and localize status epilepticus. Seizure. 2019;68:46–51. https://doi.org/10.1016/j.seizure.2018.10.010.
Giovannini G, Malagoli M, Turchi G, Miani A, Orlandi N, Vaudano AE, et al. Cortical and thalamic hyper-perfusion in non-convulsive status epilepticus. Relationship between perfusion CT patterns and Salzburg EEG criteria. Seizure. 2021;92:10–7. https://doi.org/10.1016/j.seizure.2021.08.002.
Gonzalez-Cuevas M, Coscojuela P, Santamarina E, Pareto D, Quintana M, Sueiras M, et al. Usefulness of brain perfusion CT in focal-onset status epilepticus. Epilepsia. 2019;60(7):1317–24. https://doi.org/10.1111/epi.16063.
Gugger JJ, Llinas RH, Kaplan PW. The role of CT perfusion in the evaluation of seizures, the post-ictal state, and status epilepticus. Epilepsy Res. 2020;159: 106256. https://doi.org/10.1016/j.eplepsyres.2019.106256.
Susse M, Gag K, Hamann L, Hannich MJ, von Podewils F. Time dependency of CSF cell count, lactate and blood-CSF barrier dysfunction after epileptic seizures and status epilepticus. Seizure. 2022;95:11–6. https://doi.org/10.1016/j.seizure.2021.12.007.
Dittrich TD, Baumann SM, Semmlack S, De Marchis GM, Hunziker S, Ruegg S, et al. Diagnostic yield of cerebrospinal fluid analysis in status epilepticus: an 8-year cohort study. J Neurol. 2021;268(9):3325–36. https://doi.org/10.1007/s00415-021-10447-3.
Langenbruch L, Wiendl H, Gross C, Kovac S. Diagnostic utility of cerebrospinal fluid (CSF) findings in seizures and epilepsy with and without autoimmune-associated disease. Seizure. 2021;91:233–43. https://doi.org/10.1016/j.seizure.2021.06.030.
DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39(8):833–40. https://doi.org/10.1111/j.1528-1157.1998.tb01177.x.
Raucci U, Pro S, Di Capua M, Di Nardo G, Villa MP, Striano P, et al. A reappraisal of the value of video-EEG recording in the emergency department. Expert Rev Neurother. 2020;20(5):459–75. https://doi.org/10.1080/14737175.2020.1747435.
Viloria Alebesque A, López Bravo A, Bellosta Diago E, Santos Lasaosa S, Mauri Llerda JA. Usefulness of electroencephalography for the management of epilepsy in emergency departments. Neurologia (Engl Ed). 2020;35(4):238–44. https://doi.org/10.1016/j.nrl.2017.08.008.
Máñez Miró JU, Díaz de Terán FJ, Alonso Singer P, Aguilar-Amat Prior MJ. Emergency electroencephalogram: usefulness in the diagnosis of nonconvulsive status epilepticus by the on-call neurologist. Neurologia (Engl Ed). 2018;33(2):71–7. https://doi.org/10.1016/j.nrl.2016.05.007.
McKay JH, Feyissa AM, Sener U, D’Souza C, Smelick C, Spaulding A, et al. Time is brain: the use of EEG electrode caps to rapidly diagnose nonconvulsive status epilepticus. J Clin Neurophysiol. 2019;36(6):460–6. https://doi.org/10.1097/WNP.0000000000000603.
Wright NMK, Madill ES, Isenberg D, Gururangan K, McClellen H, Snell S, et al. Evaluating the utility of rapid response EEG in emergency care. Emerg Med J. 2021;38(12):923–6. https://doi.org/10.1136/emermed-2020-210903.
Vohra TT, Miller JB, Nicholas KS, Varelas PN, Harsh DM, Durkalski V, et al. Endotracheal intubation in patients treated for prehospital status epilepticus. Neurocrit Care. 2015;23(1):33–43. https://doi.org/10.1007/s12028-014-0106-5.
Crawshaw AA, Cock HR. Medical management of status epilepticus: emergency room to intensive care unit. Seizure. 2020;75:145–52. https://doi.org/10.1016/j.seizure.2019.10.006.
Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591–600. https://doi.org/10.1056/NEJMoa1107494.
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23. https://doi.org/10.1007/s12028-012-9695-z.
Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792–8. https://doi.org/10.1056/NEJM199809173391202.
Arya R, Kothari H, Zhang Z, Han B, Horn PS, Glauser TA. Efficacy of nonvenous medications for acute convulsive seizures: a network meta-analysis. Neurology. 2015;85(21):1859–68. https://doi.org/10.1212/WNL.0000000000002142.
Brigo F, Nardone R, Tezzon F, Trinka E. A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus. CNS Drugs. 2015;29(9):741–57. https://doi.org/10.1007/s40263-015-0271-x.
Alvarez V, Lee JW, Drislane FW, Westover MB, Novy J, Dworetzky BA, et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison. Epilepsia. 2015;56(8):1275–85. https://doi.org/10.1111/epi.13056.
Kellinghaus C, Rossetti AO, Trinka E, Lang N, May TW, Unterberger I, et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol. 2019;85(3):421–32. https://doi.org/10.1002/ana.25416.
Navarro V, Dagron C, Elie C, Lamhaut L, Demeret S, Urien S, et al. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial. Lancet Neurol. 2016;15(1):47–55. https://doi.org/10.1016/S1474-4422(15)00296-3.
Neligan A, Rajakulendran S, Walker MC. Advances in the management of generalized convulsive status epilepticus: what have we learned? Brain. 2021;144(5):1336–41. https://doi.org/10.1093/brain/awab049.
Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23(3):167–74. https://doi.org/10.1016/j.seizure.2013.12.007.
• Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125–34. https://doi.org/10.1016/S0140-6736(19)30724-X. The EcLiPSE Trial was a multicenter randomized trial that found no difference in efficacy between levetiracetam and phenytoin in cessation of seizures in pediatric patients with fewer side effects and faster infusion times of levetiracetam.
• Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet. 2019;393(10186):2135–45. https://doi.org/10.1016/S0140-6736(19)30722-6. The ConSEPT Trial was a multicenter, randomized trial establishing no statistically significant difference between levetiracetam and phenytoin in seizure cessation in pediatric patients.
Su Y, Liu G, Tian F, Ren G, Jiang M, Chun B, et al. Phenobarbital versus valproate for generalized convulsive status epilepticus in adults: a prospective randomized controlled trial in China. CNS Drugs. 2016;30(12):1201–7. https://doi.org/10.1007/s40263-016-0388-6.
Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61. https://doi.org/10.5698/1535-7597-16.1.48.
Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498–503. https://doi.org/10.1111/epi.12247.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Reba John, Daniel Grahf, Arion Lochner, Ross Taylor, Seth Krupp and Taher Vohra declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical collection on Neurologic Emergencies
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
John, R., Grahf, D., Lochner, A. et al. Evaluation and Treatment of Adult Status Epilepticus in the Emergency Department. Curr Emerg Hosp Med Rep 10, 107–115 (2022). https://doi.org/10.1007/s40138-022-00250-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40138-022-00250-3